What the results might mean for the future of other developers in the cannabinoid receptor 1 (CB1) weight-loss arena came into question after Novo Nordisk A/S unveiled phase IIa findings with ...
Route 92 Medical Inc. sped past its series F goal, raising an additional $50 million in an extension to the oversubscribed round. The extension brings the total for the series F to $82 million, which ...
An innovation that has kickstarted a revolution in the study and practice of health care is getting even more attention.
Creo Medical Group plc entered into an agreement to sell a 51% stake in its European consumable business to Chinese medical ...
In what represents its first patenting, Roseville, Minn.-based Iveacare Inc. provides insights as to what its first ...
The draft Medicare physician fee schedule for calendar year 2025 provoked a strong backlash from physician societies due to a ...
Researchers from Johnson & Johnson presented the discovery of a novel inhibitor of cyclin-dependent kinase 7 (CDK7), a ...
The U.S. CMS believes it has a quandary on its hands with regard to transitional pass-through payment for renal denervation devices, but the Medical Device Manufacturers Association urged the agency ...
The specter of elevated liver enzymes, a known problem with the drug class, became a topic of talk with regard to Sanofi SA’s ...
As med-tech startups look to raise capital without diluting the valuation of their company, many may look to sell ...
DNA is open and accessible, while the action of an epigenetic editor turns it into functionally inactive DNA, which is closed ...
Cincera Therapeutics Pty Ltd. and Monash University co-presented the phenotypic drug discovery of CIN-244, a novel MRTF/SRF ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback